Aeon Astron Europe B.V.   Report issue

For profit Phase 2 Phase 4
Founded: Leiden Netherlands (2008)
Status: Acquired by Body Organ Biomedical Corporation (2008)

Organization Overview

First Clinical Trial
2009
NCT01174420
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Aeon Astron Europe B.V. | AEON Biopharma, Inc. | Aeon Biotechnology Corporation | OculusGen Biomedical Inc.

Active Ingredients

Drugs in Phase 4 Trials (2)

Key: Aeon Astron Europe B.V. (0) Acquired (2)

collagen (7 trials)

mitomycin (mutamycin) (6 trials)

Drugs in Phase 2 Trials (1)

abp-450 (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cataract (Phase 2)

Glaucoma (Phase 4)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 12
  • # of Trial APIs: 3